Privacy Policy for the Patient and Carer Peer Mentor Program

Information collection for the Patient and Carer Peer Mentor Program

In order to participate in the Patient and Carer Peer Mentor Program (“Program”), you will be required to provide personal and contact information, including medical information. Information is collected in order to provide you with the most personalized experience possible and for internal Program monitoring. It is not used for any other purposes or programs not described in this Privacy Policy.

What information is collected?

AbbVie Inc. (“AbbVie”) has contracted with Patient Health Perspectives to manage the Patient and Carer Peer Mentor Program. To facilitate your participation in the Program, Patient Health Perspectives will collect certain personal and contact information from you, including your name, disease state, phone number(s), email, age range, gender, state of residence, and how you heard about the Program. From time to time, you may also be asked to respond to surveys, which help to evaluate your satisfaction with the Program.

How is the information used?

As indicated above, your information will be used only for internal Program management and monitoring. This may include looking at trends regarding current or planned Duopa use and discontinuation.

We may also use this personal information for other business purposes, such as to offer you the opportunity to receive notices regarding AbbVie's products or services, to invite you to participate in surveys about our products, or to notify you about special promotions.

With the exception of your phone number, all of the information you provide may be shared with your Peer Mentor and Patient and Carer Peer Mentor Program staff to facilitate your participation in the Program and for internal monitoring purposes. Your phone number will not be shared with your Peer Mentor and will only be shared with the Patient and Carer Peer Mentor Program staff as necessary to facilitate contact with your Peer Mentor.

Your email address will not be sold or assigned except as outlined in this Privacy Policy.

In addition to the sharing of your personal information as described above, certain non-personally identifiable/aggregate data may be shared with AbbVie in order to enhance the quality and user satisfaction of the Patient and Carer Peer Mentor Program.

How is your information shared with third parties?

Except as otherwise described below, the personal information collected as part of the Patient and Carer Peer Mentor Program will not be shared with a third party without your permission.

AbbVie may share your personal information with third parties with whom AbbVie is jointly marketing a product or service or jointly conducting a program or activity. It is AbbVie's practice to notify you if you are registering for a program which is conducted in conjunction with another company that may require access to your personal information.

AbbVie may also share your personal information with vendors with whom AbbVie contracts to carry out business activities for AbbVie. In the ordinary course of business, personal information collected from you as part of the Patient and Carer Peer Mentor Program may be shared with companies hired to perform services or functions for the Patient and Carer Peer Mentor Program. For example, a third party service provider is responsible for developing and maintaining the Program website. Consequently, this provider will have access to the personal information you provide as part of the Program in the ordinary course of business. However, in this instance, and all instances in which your personal information is shared with a third party, such party will not be authorized to keep, disclose or use your information with others except for the purpose of providing the services they have been asked to provide.

Your personal information will not be sold or published, except in conjunction with a corporate sale, merger, dissolution, or acquisition.

We may be legally compelled to release your personal information in response to a court order, subpoena, search warrant, law or regulation. We may cooperate with law enforcement authorities in investigating and prosecuting website visitors who violate our rules or engage in behavior which is harmful to other visitors (or illegal).

In addition, your personal information may be disclosed to third parties if we feel that the disclosure is necessary to:

  • Enforce this Privacy Policy and the other rules about your participation in the Patient and Carer Peer Mentor Program
  • Protect our rights or property
  • Protect someone's health, safety or welfare
  • Comply with a law or regulation, court order or other legal process

Please note: In addition to the ways that your personal information is maintained, disclosed, and used as described in this Privacy Policy, your personal information may also be maintained, disclosed, or used in ways that we believe are consistent with FDA and other governmental guidance, directions, regulations, and laws.

What happens if the Privacy Policy changes?

If we decide to make a significant change to our Privacy Policy, we will post a notice on the homepage of our website for thirty (30) days after the change is made. www.duopamentor.com AbbVie reserves the right to change the terms of our Privacy Policy at any time in its sole discretion. Please periodically revisit this page to stay current on any changes and to update your preferences accordingly.

What about privacy on other websites?

This website may contain links to other websites. Some of those websites may be operated by AbbVie, and some may be operated by third parties. We provide the links for your convenience, but we do not review, control, or monitor the activities or privacy practices of websites operated by others, and we do not endorse, condone, adopt, or accept liability for any statements made on websites to which we provide links. This Privacy Policy does not apply to any other website, even those owned by AbbVie. We are not responsible for the performance of websites operated by third parties or for your business dealings with them. Therefore, whenever you leave this website, we recommend that you review each website's privacy practices and make your own conclusions regarding the adequacy of these practices.

In addition, if you choose to contact AbbVie directly using the "Contact AbbVie" option on the website, all information provided to AbbVie will be treated in accordance with AbbVie's Privacy Statement.

Are there special rules about children's privacy?

We care about protecting the online privacy of children. This website is not intended for use by children under the age of 18. We will not intentionally collect any personal information (such as a child's name or email address) from children under the age of 18. If you are a child under age 18, please do not send us any information about yourself. If you think that we have collected personal information from a child under the age of 18, please contact us. We encourage all parents and guardians to monitor their children's use of the Internet.

What about website security?

We take reasonable steps to protect your personal information from loss, misuse, and unauthorized access, disclosure, alteration, or destruction. You should keep in mind that no Internet transmission is ever 100 percent secure or error-free.

Use

DUOPA (carbidopa and levodopa) enteral suspension is a prescription medicine used for treatment of advanced Parkinson’s disease. DUOPA contains two medicines: carbidopa and levodopa.

Important Safety Information

What is the most important safety information I should know about DUOPA?

  • Stomach and intestine (gastrointestinal) problems and problems from the procedure you will need to have to receive DUOPA (gastrointestinal procedure-related problems) may occur. Some of these problems may require surgery and may lead to death.

Your healthcare provider will talk to you about the stoma procedure. Before the stoma procedure, tell your healthcare provider if you ever had a surgery or problems with your stomach.

Talk to your healthcare provider about what you need to do to care for your stoma.
After the procedure, you and your healthcare provider will need to regularly check the stoma for any signs of infection.

  • Symptoms of infection may include: drainage, redness, swelling, pain, or feeling of warmth around the small hole in your stomach wall (stoma).

Tell your healthcare provider right away if you have any of the following symptoms of stomach and intestine problems and gastrointestinal procedure-related problems: stomach (abdominal) pain; constipation that does not go away; nausea or vomiting; fever; blood in your stool; or a dark tarry stool.

Do not take DUOPA if you currently take or have recently taken (within 2 weeks) a medication for depression called a non-selective monoamine oxidase (MAO) inhibitor. Ask your healthcare provider or pharmacist if you are not sure if you take an MAO inhibitor.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using DUOPA with certain other medicines, including medications for high blood pressure, MAO inhibitors, antipsychotics, metoclopramide, isoniazid, and iron or vitamin supplements, may cause serious side effects. High-protein foods may affect how DUOPA works. Tell your healthcare provider if you change your diet.

DUOPA may cause serious side effects. Talk to your doctor before starting DUOPA and while on DUOPA if you have had or have any of these:

  • Falling asleep during normal daily activities without warning. DUOPA may cause you to fall asleep while you are doing daily activities such as driving, which may result in an accident. This can happen as late as one year after starting DUOPA. Do not drive or operate machinery until you know how DUOPA affects you. Tell your healthcare provider if you take medicines that can make you sleepy, such as sleep medicines, antidepressants, or antipsychotics.

  • Low blood pressure when you stand or sit up quickly. After you have been sitting or lying down, stand up slowly to help reduce dizziness, nausea, sweating, or fainting until you know how DUOPA affects you.

  • Seeing, hearing, or feeling things that are not real (hallucinations).

  • Unusual urges. Some people taking medicines for Parkinson’s disease, including DUOPA, have reported urges such as excessive gambling, compulsive eating, compulsive shopping, and increased sex drive.

  • Depression and suicide. DUOPA can cause or worsen depression. Pay close attention to changes in your mood, behavior, thoughts, or feelings. Call your healthcare provider right away if you feel depressed or have thoughts of suicide.

  • Uncontrolled sudden movements (dyskinesia). If you have new dyskinesia or your dyskinesia gets worse, tell your healthcare provider. This may be a sign that your dose of DUOPA or other Parkinson’s medicines may need to be adjusted.

  • Progressive weakness or numbness or loss of sensation in the fingers or feet (neuropathy).

  • Heart attack or other heart problems. Tell your healthcare provider if you have experienced increased blood pressure, a fast or irregular heartbeat, or chest pain.

  • Parkinson's disease patients are at an increased risk of developing melanoma, a form of skin cancer. See your healthcare provider for regular skin examinations when taking DUOPA.

  • Abnormal blood tests. DUOPA may cause changes in certain blood tests, especially certain hormone and kidney blood tests.

  • Worsening of the increased pressure in your eyes (glaucoma). The pressure in your eyes should be checked after starting DUOPA.

Do not stop using DUOPA or change your dose unless you are told to do so by your healthcare provider. Tell your healthcare provider if you develop withdrawal symptoms such as fever, confusion, or severe muscle stiffness.

The most common side effects of DUOPA include: complications of tubing placement procedure, swelling of legs and feet, nausea, high blood pressure (hypertension), depression, and mouth and throat pain.

Please see the full Prescribing Information including Medication Guide for additional information about DUOPA. Talk to your healthcare provider if you have questions.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.1-800-FDA-1088.

If you cannot afford your medication, contact www.pparx.org for assistance.

Important Safety Information

What is the most important safety information I should know about DUOPA?

  • Stomach and intestine (gastrointestinal) problems and problems from the procedure you will need to have to receive DUOPA (gastrointestinal procedure-related problems) may occur. Some of these problems may require surgery and may lead to death.